On July 9, the Hong Kong stock market experienced a decline with the Hang Seng Index (HSI) down 1.06%, the Hang Seng China Enterprises Index (HSCEI) down 1.28%, and the Hang Seng Tech Index (HSTECH) down 1.76%.

China’s factory deflation persisted into a 33rd month, with the producer price index falling 3.6% compared to May’s 3.3% drop. Consumer prices unexpectedly rose in June, according to data released Wednesday.

Star Plus Legend up 94%; Hengrui Pharma up 15.6%; LENS up 9%; CATL up 7%; Tencent down 1.4%; Xiaomi down over 2%; Alibaba down 3.8%.

Hong Kong stock Star Plus Legend, which is tied to pop star Jay Chou, continue to soar 142.5% on Wednesday. Douyin confirmed that Taiwanese superstar Jay Chou has joined its platform with the verified account "Zhou Tong Xue (literal translation of "周同學", meaning "Classmate Chou"), certified as a singer, amassing 50,000 followers within 10 minutes. Earlier rumors of a nine-figure signing fee were dismissed by a Douyin spokesperson as false.

Hengrui Pharma's stock price surged over 15% after its SHR-2173 injection received clinical trial approval, marking a new high. This rise was part of a broader increase in pharmaceutical stocks, with Luye Pharma up over 8% and Sino Biopharm rising by more than 10%.

CATL's stock rose by 7% to a new high, following the announcement of a $6 billion battery integration project in Indonesia and a strategic cooperation agreement with Geely Auto. Meanwhile, Geely Auto's stock increased by 2.78%.

In contrast, CMOC saw a decline of 4.74%, and NCI fell by 3.79% as the insurance sector was affected by fluctuations in the ten-year government bond yield. BYD Company and XPeng-W also experienced declines of 1.14% and 2.11%, respectively.

LENS, a producer of protective panels for electronic products, up 9% in strong trading debut in Hong Kong on Wednesday.